The Hyderabad-based GVK Biosciences (GVK BIO), Asia’s leading drug discovery research & development organization, announced today that it has entered into a drug discovery alliance with the Moulder Center for Drug Discovery Research at Temple University.
Indian government today told pharmaceutical industry not to 'grumble' over the proposed drug pricing policy saying affordability and accessibility of medicines should be the first consideration.
Bio Bodyfuelz Ltd, the Pioneers in sports and performance nutrition, has tied up with online Nutritional Supplement leader MyNutraMart.com for online sales for Bodyfuelz range of products. The products which will be sold on MyNutraMart.com are Bodyfuelz Musclemax, Bodyfuelz Fastcharge, Bodyfuelz Fat Burner, Bodyfuelz PWRSports, Bodyfuelz Fitnez, Bodyfuelz Glucosamine, and Bodyfuelz Glutamaxxx.
Hyderabad-based GVK Biosciences today said it has entered into a drug discovery alliance with Philadelphia-based Moulder Centre for Drug Discovery Research at Temple University.
Vandana Luthra Curles and Curves, the Delhi based firm, riding high on the growing demand for skincare products announced that it will open 60 more exclusive outlets with an investment of Rs 40 crore.
One of India's leading drug manufacturing firm Lupin has targeted a revenue of $ 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US market by 2013-14, a segment in which it had forayed recently.
Stemade Biotech, a pioneer in Dental Stem Cell Banking in Asia region and India's first player in Dental Stem Cell Banking today announced the launch of its operations in Chandigarh after its successful launch in Delhi, Mumbai, Pune, Hyderabad, Chennai and Bangalore.
Loyola Insititute of Business Administraion (LIBA) yesterday announced the winners of the fourth edition of ESPIRE 2011 – Pan India Business Plan Challenge that was held at sylvan surroundings of LIBA Campus in Nungambakkam, Chennai.
BioAsia 2012 will be held in Hyderabad, from February 09 to 11, 2012. In its ninth edition, BioAsia 2012 will focus on CROs, IPR, Vaccines and Inves.
The Hyderabad based pharmaceutical firm Transgene Biotek is planning to sell one of its bio-generic products, Erythropoientin to German firm Tss Export GmbH FZE for a total consideration of $ 5 million (Rs 26 crore), the company said in a filing to the BSE.
Dr Reddy's Laboratories yesterday said one of its promoter firms has sold 19.3 crore non-convertible debentures for Rs 100.17 crore through an open market sale.
As the Pakistan government, after its decision to award most favoured nation (MFN) status to India, is trying to finalise the negative list, the Pakistani pharmaceutical companies have expedited their efforts to convince the government for banning imports of finished medicines from India, Pakistan newspaper The Express Tribune has reported from Karachi on Sunday.
One of India's leading pharmaceutical firms, Dr Reddy's Laboratories yesterday said the agitating workers at its manufacturing facility in Srikakulam, Andhra Pradesh, have called off three-month old strike and the plant has resumed normal operations.
Indian pharma major Dr Reddy's Laboratories has requested the government to denotify its Special Economic Zone (SEZ) at Medak in Andhra Pradesh.
A new global market report on 'Orthopedic Implants' has been released by Industry Experts. According to the report, the global market for orthopedic implants is projected to reach US$ 46.5 billion by 2017 from an estimated US$ 21.1 billion in 2007.
